RecruitingNot ApplicableNCT06152341

Safety and Effectiveness of the ATC System in the Treatment of Acute PE

Safety and Effectiveness of the ATC System in the Treatment of Acute Pulmonary Embolism

Sponsor

Akura Medical

Enrollment

30 participants

Start Date

May 15, 2024

Study Type

INTERVENTIONAL

Conditions

Pulmonary Embolism Acute

Summary

This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of the ATC System in subjects with acute pulmonary embolism (PE).

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called ATC System for people with pulmonary embolism acute. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.